Letter to the Editor:Tenofovir Resistance among HIV-Infected Patients Failing a Fixed-Dose Combination of Stavudine, Lamivudine, and Nevirapine in a Resource-Limited Setting

This publication has 8 references indexed in Scilit:

• Options for a Second-Line Antiretroviral Regimen for HIV Type 1-Infected Patients Whose Initial Regimen of a Fixed-Dose Combination of Stavudine, Lamivudine, and Nevirapine Fails
  Clinical Infectious Diseases, 2007
• Experience with the use of a first‐line regimen of stavudine, lamivudine and nevirapine in patients in the TREAT Asia HIV Observational Database
  HIV Medicine, 2007
• Resistance development over 144 weeks in treatment‐naive patients receiving tenofovir disoproxil fumarate or stavudine with lamivudine and efavirenz in Study 903^*
  HIV Medicine, 2006
• Personalised social care for adults with disabilities: a problematic concept for frontline practice
  Health & Social Care in the Community, 2006
• Management of HIV-1 Infection With a Combination of Nevirapine, Stavudine, and Lamivudine
  JAIDS Journal of Acquired Immune Deficiency Syndromes, 2005
• Efficacy of Highly Active Antiretroviral Therapy in HIV-Infected Children Participating in Thailand's National Access to Antiretroviral Program
  Clinical Infectious Diseases, 2005
• Effectiveness of Generic Fixed-Dose Combinations of Highly Active Antiretroviral Therapy for Treatment of HIV Infection in India
  JAIDS Journal of Acquired Immune Deficiency Syndromes, 2004
• Genotypic and Phenotypic Predictors of the Magnitude of Response to Tenofovir Disoproxil Fumarate Treatment in Antiretroviral‐Experienced Patients
  The Journal of Infectious Diseases, 2004